Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Waters Corp (NY:WAT)

381.53 +10.33 (+2.78%)
Streaming Delayed Price Updated: 1:34 PM EDT, Jul 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Waters Corp

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
What Analysts Are Saying About Waters Stock ↗
 
Via Benzinga
News headline image
Meta To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
WAT Stock Earnings: Waters Beats EPS, Beats Revenue for Q2 2024 ↗
WAT stock results show that Waters beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Pinterest Issues Weak Revenue Forecast, Joins Groupon, O-I Glass And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Expert Ratings For Waters ↗
 
Via Benzinga
News headline image
Assessing Waters: Insights From 4 Financial Analysts ↗
 
Via Benzinga
News headline image
Navigating 4 Analyst Ratings For Waters ↗
 
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Waters Through 4 Analysts ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 6, 2024 ↗
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. 
Via Benzinga
News headline image
Insiders Buying Hilton Worldwide And 2 Other Stocks ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Laboratory Instruments Company Waters Corp Projects Steady Growth Amid Global Sales Fluctuations: Details ↗
Waters Corp (NYSE: WAT) reported Q1 2024 sales of $636.8 million, beating analyst consensus. Quarterly rev declined 7%. Adjusted EPS was $2.21, beating Wall Street estimate. Outlook: full-year org... 
Via Benzinga
News headline image
WAT Stock Earnings: Waters Beats EPS, Beats Revenue for Q1 2024 ↗
WAT stock results show that Waters beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs ↗
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates. 
Via Benzinga
News headline image
The Latest Analyst Ratings For Waters ↗
 
Via Benzinga
News headline image
Where Waters Stands With Analysts ↗
 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Waters ↗
 
Via Benzinga
News headline image
Buy the Dip: 3 Oversold Stocks Poised for Big Gains ↗
Discover how these oversold stocks to buy point towards potential fast gains while their fundamentals support potentially further growth. 
Via InvestorPlace
News headline image
Waters Q4 Earnings Beats Estimates, CEO Touts Strong Execution In Tough Market Conditions ↗
Waters Corporation beats Q4 earnings estimates, outlining mixed regional sales performance and cautious outlook for 2024. 
Via Benzinga
Topics Earnings
News headline image
Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones falling around 90 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Waters ↗
 
Via Benzinga
News headline image
HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
News headline image
What's Going On With Laboratory Instrument & Software Company Waters' Shares Today? ↗
Waters Corporation (NYSE: WAT) shares are trading higher after the company  
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 7, 2023 ↗
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Robo-Lab Stocks: 3 Robotics Companies Changing the Research Game ↗
Robotics will upend laboratory research just as they upended factories. Bet on the future with these 3 robo-lab company stocks. 
Via InvestorPlace
News headline image
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract. 
Via Benzinga
News headline image
Humana, Waters, e.l.f. Beauty, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Powell Industries, Inc. (NASDAQ: POWL) shares jumped... 
Via Benzinga
News headline image
Earnings Scheduled For August 2, 2023 ↗
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.